The primary focus of our laboratory is the understanding of how the brain regulates blood pressure.

We study the neurotransmitter, peptide and cellular mechanisms in central brain nuclei that regulate sympathetic outflow and ultimately arterial blood pressure.

Our ultimate goal is to identify potential new phamacotherapies that will improve the lives of individuals who suffer from cardiovascular disease.

Current studies include understanding mechanisms underlying cognitive changes that occur with cardiovascular disease.